Related Experiment Videos
Defensins and mucosal protection
1Division of Gastroenterology, Institute of Infection, Immunity and Inflammation, University of Nottingham and University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Novartis Foundation Symposium
|January 27, 2005
Summary
Epithelial cells in the gut produce antimicrobial peptides like human defensins (HD5, HD6, HBD1, HBD2) to protect against bacteria. These defensins also play a role in regulating immune responses, particularly in inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- The gastrointestinal tract harbors a complex bacterial population, necessitating host defense mechanisms.
- Epithelial cells are crucial in mediating protective responses against resident microorganisms.
- Antimicrobial peptides, particularly defensins, are increasingly recognized for their role in gut immunity.
Purpose of the Study:
- To investigate the role of enteric alpha-defensins (HD5, HD6) and human beta-defensins (HBD1, HBD2) in intestinal epithelial defense.
- To understand the expression patterns and processing of these defensins in health and inflammatory bowel disease (IBD).
- To explore the potential immunomodulatory functions of defensins in the context of IBD.
Main Methods:
- Analysis of defensin expression in intestinal epithelial cells, including Paneth cells.
- Investigation of the processing of alpha-defensins (HD5) from precursor to mature forms.
- Examination of defensin expression changes in inflammatory bowel disease models or patients.
Main Results:
- Enteric alpha-defensins (HD5, HD6) are expressed by Paneth cells, with HD5 requiring processing.
- Human beta-defensin 1 (HBD1) is constitutively expressed, while HBD2 expression is induced in inflammatory bowel disease.
- Defensins (HBDs) exhibit chemotactic properties for immune cells like dendritic cells and T cells.
Conclusions:
- Intestinal epithelial cells utilize defensins as a key component of innate immunity against luminal bacteria.
- Defensins may bridge innate and adaptive immunity by influencing immune cell migration and function.
- Altered expression of defensins in inflammatory bowel disease suggests a role in disease pathogenesis and regulation.